相关实验视频
Updated: Jun 7, 2025

14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
6.9K
振荡计定义的小气道功能障碍是喘中可治疗的特征.
Marcello Cottini1, Carlo Lombardi2, Pasquale Comberiati3
1Allergy and Pneumology Outpatient Clinic, Bergamo, Italy.
概括
小气道功能障碍,肺部的静音区,与喘控制不良有关. 识别和治疗这些问题可能会个性化喘管理并改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 喘研究 喘研究
背景情况:
- 小气道,或肺部的静音区,在喘管理中至关重要.
- 小气道功能障碍与症状控制不良和喘恶化增加有关.
- 个性化喘护理正在通过'可治疗特征'范式发展.
研究的目的:
- 审查关于小气道功能障碍作为持久性喘中可治疗的特征的文献.
- 探索振荡计在评估小气道中的作用.
- 检查先进疗法对外围呼吸道疾病的影响.
主要方法:
- 对喘中小气道功能障碍研究的文献综述.
- 对振荡计技术 (全呼吸和内呼吸) 的分析.
- 对外微型吸入性皮质类固醇和系统性生物制剂在周围呼吸道治疗中的证据的评估.
主要成果:
- 小呼吸道功能障碍是持续性喘的一个重要因素.
- 振荡计为空气流阻力和反应率提供了宝贵的见解.
- 额外的吸入性皮质类固醇和全身生物药物显示出在管理周围气道阻塞方面的潜力.
结论:
- 小气道功能障碍是喘中可治疗的关键特征.
- 振荡计是诊断和监测小呼吸道疾病的一个有前途的工具.
- 向治疗为个性化喘管理提供了新的途径.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237

